Key terms
About LH
Laboratory Corp. of America Holdings operates as a life sciences company, which engages in the provision of vital information to help health professionals make clear and confident decisions. It operates through the Drug Development and Diagnostics segments. The Drug Development segment consists of lead optimization, preclinical safety assessment, analytical services, clinical trials, central laboratories, biomarkers, and companion diagnostics, market access, and technology solutions. The Diagnostics segment includes primary care, women's health, specialty medicine, oncology, ACOs, and hospitals and health systems. The company was founded in 1971 and is headquartered in Burlington, NC.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest LH news
Apr 30
8:36am ET
Final LDT rule lifts overhang on Quest and Labcorp, says Jefferies
Apr 30
8:01am ET
Analysts’ Top Healthcare Picks: Laboratory (LH), Amgen (AMGN)
Apr 30
3:20am ET
Analysts Offer Insights on Healthcare Companies: Edwards Lifesciences (EW), Bristol-Myers Squibb (BMY) and Laboratory (LH)
Apr 30
2:47am ET
Strong Performance and Strategic Acquisitions Justify Buy Rating for Laboratory Corporation of America Holdings
Apr 29
7:03am ET
Labcorp: FDA approves nAbCyte Anti-AAVRh74var HB-FE Assay
Apr 26
7:30am ET
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Laboratory (LH), Fusion Pharmaceuticals (FUSN) and Integer Holdings (ITGR)
Apr 26
6:51am ET
Labcorp price target lowered to $244 from $255 at Baird
Apr 26
6:25am ET
Labcorp price target lowered to $213 from $234 at Barclays
Apr 26
5:25am ET
Analysts Offer Insights on Healthcare Companies: Universal Health (UHS), Laboratory (LH) and Bristol-Myers Squibb (BMY)
Apr 26
4:48am ET
Laboratory (LH) Receives a Hold from Barclays
Apr 25
7:19am ET
Labcorp narrows FY24 adjusted EPS view to $14.45-$15.35 from $14.30-$15.40
Apr 25
7:16am ET
Labcorp reports Q1 adjusted EPS $3.68, consensus $3.48
Apr 25
6:08am ET
Labcorp wins bid to purchase assets of Invitae for $239M
Apr 24
9:24pm ET
Invitae enters into agreement with Labcorp for $239M sale of business
Apr 24
8:25pm ET
Notable companies reporting before tomorrow’s open
Apr 24
2:22pm ET
Notable companies reporting before tomorrow’s open
Apr 16
6:00am ET
Analysts Offer Insights on Healthcare Companies: Verastem (VSTM), Laboratory (LH) and Longboard Pharmaceuticals (LBPH)
Apr 05
8:20am ET
Analysts Offer Insights on Healthcare Companies: Genfit SA (GNFT) and Laboratory (LH)
Apr 05
7:03am ET
Labcorp announces launch of Labcorp Plasma Detect
Apr 01
8:20am ET
Labcorp ,Xcell Biosciences deepen tie-up, adding new elements to collaboration
Mar 28
8:03am ET
Labcorp to acquire select assets of BioReference Health for $237.5M
Mar 25
9:44am ET
Tesla downgraded, Disney upgraded: Wall Street’s top analyst calls
Mar 25
8:43am ET
Argus upgrades Labcorp to Buy on stronger top-line growth, margin expansion
Mar 25
7:26am ET
Labcorp upgraded to Buy from Hold at Argus
Mar 07
12:00am ET
Analysts Have Conflicting Sentiments on These Healthcare Companies: Laboratory (LH), Apellis Pharmaceuticals (APLS) and Iovance Biotherapeutics (IOVA)
Mar 05
7:11am ET
Labcorp partners with Pinnacle Fertility
Feb 27
11:40pm ET
Analysts Offer Insights on Healthcare Companies: Cogent Biosciences (COGT), Celldex (CLDX) and Laboratory (LH)
Feb 26
9:34am ET
Moderna downgraded, Gap upgraded: Wall Street’s top analyst calls
Feb 26
6:20am ET
Labcorp initiated with an Outperform at Leerink
Feb 21
8:21am ET
Biomerica appoints Gary Huff to strategic advisory board
Feb 19
12:45am ET
Buy Rating for Laboratory Corp. as Strong Financials and Growth Prospects Shine
No recent press releases are available for LH
LH Financials
Key terms
Ad Feedback
LH Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
LH Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
